Japan COVID-19 Nucleic Acid Detection Kit Market was valued at USD 1.1 Billion in 2022 and is projected to reach USD 1.7 Billion by 2030, growing at a CAGR of 5.9% from 2024 to 2030.
Japan's COVID-19 Nucleic Acid Detection Kit Market: Types and Industry Requirements
In the face of the COVID-19 pandemic, Japan's market for nucleic acid detection kits has rapidly evolved to meet the urgent demands of various industries. These kits, essential for accurate and timely diagnosis, have become pivotal in controlling the virus's spread.
Types of Nucleic Acid Detection Kits Available in Japan
RT-PCR Kits: The real-time reverse transcription polymerase chain reaction (RT-PCR) method is the gold standard for detecting SARS-CoV-2. Kits such as the "2019-nCoV Fluorescence Detection Real-time RT-PCR Kit" by Sysmex Corporation and the "cobas SARS-CoV-2" by Roche Diagnostics K.K. have been authorized for use in Japan. These kits offer high sensitivity and specificity, making them reliable for clinical diagnostics.
LAMP Kits: Loop-mediated isothermal amplification (LAMP) is another nucleic acid amplification method that allows for rapid detection. The "Loopamp Novel Coronavirus 2019 (SARS-CoV-2) Detection Kit" by Eiken Chemical Co., Ltd. is an example of a LAMP-based test authorized in Japan. LAMP kits are valued for their speed and do not require sophisticated equipment, making them suitable for point-of-care testing.
Industry Requirements and Preferences
Industries across Japan have specific requirements when selecting nucleic acid detection kits:
Speed and Efficiency: Industries require kits that provide rapid results to minimize downtime and ensure quick decision-making. For instance, Shimadzu Corporation's "2019 Novel Coronavirus Detection Kit" reduces labor and halves detection time by eliminating RNA extraction and purification steps, delivering results in approximately one hour.
Accuracy and Reliability: High sensitivity and specificity are paramount to avoid false negatives or positives. Kits like the "LumiraDx SARS-CoV-2 Ag Test Strip," co-marketed by Shionogi & Co., Ltd., offer results comparable to PCR tests with a positive agreement rate of 97.5% and a negative agreement rate of 97.7%, providing confidence in the results.
Ease of Use: Kits that are user-friendly and do not require specialized equipment are preferred, especially in non-specialized medical institutions. The "QuickNavi™- COVID-19 Ag" diagnostic kit by Otsuka Pharmaceutical Co., Ltd. provides results in 15 minutes using a simple procedure, making it accessible for widespread use.
Regulatory Approval and Availability: Ensuring that kits have proper authorization and are readily available is crucial. The Japanese Ministry of Health, Labour and Welfare maintains a list of authorized in vitro diagnostics for COVID-19, which serves as a reference for industries to select approved kits.
Personal Experience with Nucleic Acid Detection Kits
In my experience working in the healthcare sector, the demand for efficient and reliable COVID-19 detection kits has been unprecedented. The introduction of kits that streamline the testing process, such as those eliminating the RNA extraction step, has significantly improved workflow efficiency. Additionally, the availability of rapid antigen tests has been instrumental in settings where quick screening is essential, although they are typically used in conjunction with nucleic acid tests for confirmation.
As industries continue to adapt to the challenges posed by the pandemic, the evolution and availability of diverse nucleic acid detection kits play a crucial role in ensuring public health and safety. The ongoing development and authorization of new kits will likely continue to meet the varying needs of different sectors, from healthcare to manufacturing.
Get an In-Depth Research Analysis of the Japan COVID-19 Nucleic Acid Detection Kit Market Size And Forecast [2025-2032]
Â
PerkinElmer
Shanghai Sidi Biomedical Technology
Jiangsu Weidi Biomedical Technology
CapitalBio Corporation
Shenzhen Zijian Biotechnology
Sun Yat-Sen University Daan Gene
Shanghai Berger Medical Technology
Shanghai Zhijiang Biotechnology
Shengxiang Biotechnology
Yaneng Biotechnology Shenzhen
BGI Wuhan
Guangzhou Wanfu Biotechnology
Zhuhai Livzon Reagent
Guangdong Hexin Health Technology
Innotek (Tangshan) Biotechnology
Mike Bio
Wuhan Mingde Biotechnology
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan COVID-19 Nucleic Acid Detection Kit Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan COVID-19 Nucleic Acid Detection Kit Market
Real-Time PCR Kits
RT-PCR Kits
LAMP Kits
Isothermal Amplification Kits
Multiplex Kits
Hospitals
Diagnostic Laboratories
Research Institutes
Home Care Settings
Pharmaceutical Companies
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Microarray Technology
CRISPR-based Technology
Magnetic Bead-based Technology
Nasal Swabs
Throat Swabs
Saliva Samples
Bronchoalveolar Lavage (BAL) Fluid
Blood Samples
Direct Sales
Distributors
Online Sales
Retail Pharmacies
Health Care Institutions
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan COVID-19 Nucleic Acid Detection Kit Market Research Analysis
1. Introduction of the Japan COVID-19 Nucleic Acid Detection Kit Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan COVID-19 Nucleic Acid Detection Kit Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan COVID-19 Nucleic Acid Detection Kit Market, By Type
6. Japan COVID-19 Nucleic Acid Detection Kit Market, By Application
7. Japan COVID-19 Nucleic Acid Detection Kit Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan COVID-19 Nucleic Acid Detection Kit Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/